| Form type | Sec Links | Description | Filing date | Reporting date |
|---|---|---|---|---|
| SC 13G | Report | SC 13G | Feb 14, 2024 | |
| SC 13G/A | Report | SCHEDULE 13G/A | Feb 13, 2024 | |
| SC 13G/A | Report | SC 13G/A | Feb 9, 2023 | |
| SC 13G/A | Report | SCHEDULE 13G/A | Feb 9, 2023 | |
| SC 13G/A | Report | SC 13G/A | Feb 14, 2022 | |
| SC 13G/A | Report | Feb 14, 2022 | ||
| SC 13G/A | Report | Feb 11, 2022 | ||
| SC 13G/A | Report | SCHEDULE 13G/A | Feb 10, 2022 | |
| SC 13G/A | Report | SC 13G/A | Feb 10, 2022 | |
| SC 13G/A | Report | SCHEDULE 13G/A | Oct 12, 2021 | |
| SC 13G/A | Report | SC 13G/A | May 7, 2021 | |
| SC 13G/A | Report | Feb 16, 2021 | ||
| SC 13G | Report | SC 13G | Feb 12, 2021 | |
| SC 13G/A | Report | SC 13G/A | Feb 11, 2021 | |
| SC 13G/A | Report | Feb 11, 2021 | ||
| SC 13G/A | Report | SCHEDULE 13G/A | Feb 10, 2021 | |
| SC 13G | Report | Feb 9, 2021 | ||
| SC 13G/A | Report | SC 13G/A | Oct 8, 2020 | |
| SC 13G | Report | Feb 14, 2020 | ||
| SC 13G/A | Report | Feb 13, 2020 | ||
| SC 13G/A | Report | SCHEDULE 13G/A | Feb 12, 2020 | |
| SC 13G/A | Report | SC 13G/A | Feb 10, 2020 | |
| SC 13G/A | Report | SC 13G/A | Feb 13, 2019 | |
| SC 13G | Report | Feb 12, 2019 | ||
| SC 13G/A | Report | Feb 12, 2019 | ||
| SC 13G/A | Report | SC 13G/A | Feb 13, 2018 | |
| SC 13G/A | Report | SC 13G/A | Feb 13, 2018 | |
| SC 13G/A | Report | Feb 9, 2018 | ||
| SC 13G/A | Report | SC 13G/A | Feb 14, 2017 | |
| SC 13G/A | Report | Feb 14, 2017 | ||
| SC 13G/A | Report | SC 13G/A | Feb 13, 2017 | |
| SC 13G/A | Report | Feb 10, 2017 | ||
| SC 13G/A | Report | Nov 3, 2016 | ||
| SC 13G/A | Report | SC 13G/A | Feb 12, 2016 | |
| SC 13G/A | Report | Feb 12, 2016 | ||
| SC 13G | Report | Feb 12, 2016 | ||
| SC 13G/A | Report | LIGAND PHARMACEUTICALS INC | Feb 12, 2016 | |
| SC 13G/A | Report | Feb 10, 2016 | ||
| SC 13G | Report | SC 13G | Feb 9, 2016 | |
| SC 13G/A | Report | SC 13G/A LGNDZ | Feb 5, 2016 | |
| SC 13G | Report | SC 13G LGNDZ | Feb 3, 2016 | |
| SC 13G/A | Report | SC 13G/A | Jul 2, 2015 | |
| SC 13G/A | Report | AMENDMENT NO. 10 TO SCHEDULE 13G | Feb 17, 2015 | |
| SC 13G/A | Report | Feb 13, 2015 | ||
| SC 13G/A | Report | LIGAND PHARMACEUTICALS INC | Feb 12, 2015 | |
| SC 13G | Report | Feb 12, 2015 | ||
| SC 13G | Report | Feb 10, 2015 | ||
| SC 13G/A | Report | SC 13G/A | Feb 4, 2015 | |
| SC 13G/A | Report | Aug 21, 2014 | ||
| SC 13G/A | Report | LIGAND13GAM2DEC13 | Feb 14, 2014 | |
| SC 13G/A | Report | DISCLOSURE DOCUMENT | Feb 14, 2014 | |
| SC 13G | Report | Feb 14, 2014 | ||
| SC 13G | Report | LIGAND PHARMACEUTICALS INC | Feb 14, 2014 | |
| SC 13G/A | Report | Feb 12, 2014 | ||
| SC 13G | Report | SC 13G | Feb 6, 2014 | |
| SC 13G/A | Report | Dec 6, 2013 | ||
| SC 13G/A | Report | Feb 14, 2013 | ||
| SC 13G/A | Report | DISCLOSURE DOCUMENT | Feb 14, 2013 | |
| SC 13G/A | Report | AMENDMENT NO. 1 | Feb 14, 2013 | |
| SC 13G | Report | Feb 13, 2013 | ||
| SC 13G | Report | SC 13G | Jan 11, 2013 | |
| SC 13G | Report | Dec 26, 2012 | ||
| SC 13G/A | Report | DISCLOSURE DOCUMENT | Feb 14, 2012 | |
| SC 13G/A | Report | Feb 9, 2012 | ||
| SC 13G/A | Report | SC 13G/A | Feb 8, 2012 | |
| SC 13G/A | Report | DISCLOSURE DOCUMENT | Dec 12, 2011 | |
| SC 13G/A | Report | AMENDMENT NO. 6 TO THE SCHEDULE 13G | Nov 23, 2011 | |
| SC 13G/A | Report | AMENDMENT NO. 5 TO THE SCHEDULE 13G | Jun 29, 2011 | |
| SC 13G/A | Report | AMENDMENT NO. 4 TO THE SCHEDULE 13G | Feb 14, 2011 | |
| SC 13G/A | Report | SEC FILING | Feb 14, 2011 | |
| SC 13G | Report | Feb 10, 2011 | ||
| SC 13G/A | Report | SC 13G/A | Jan 31, 2011 | |
| SC 13G/A | Report | AMENDMENT NO. 3 TO THE SCHEDULE 3G | Feb 12, 2010 | |
| SC 13G/A | Report | SEC FILING | Feb 12, 2010 | |
| SC 13G/A | Report | SC 13G/A | Feb 11, 2010 |